StockPriceToday
Copart Inc (CPRT)
About Copart Inc
Copart Inc. provides online auctions and vehicle remarketing services for automotive dealers, rental car companies, banks, and insurance companies worldwide. The company's technology-enabled auction platform has made CPRT stock price sensitive to vehicle accident rates, used car demand, and automotive industry trends.
Copart's online auction platform enables buyers worldwide to bid on damaged, aged, and low-value vehicles through internet-based auctions. The company's technology solutions help sellers maximize vehicle values while providing buyers with convenient access to inventory.
The company's network of storage facilities and transportation services provides comprehensive vehicle processing and logistics solutions. Copart's expansion into international markets and additional vehicle categories demonstrates its growth strategy, affecting CPRT stock price performance.
Copart's asset-light business model and technology advantages have enabled consistent profitability and market share growth. The company's ability to leverage technology innovation while expanding globally remains important for its continued success in the vehicle remarketing industry.
CPRT Stock 12 Month Chart
Latest News for CPRT
Buying $100 In CPRT: If an investor had bought $100 of CPRT stock 10 years ago, it would be worth $908.53 today based on a price of $40.73 for CPRT at the time of writing.
Copart, Inc. (NASDAQ:CPRT) is included in our list of the 13 Best Extremely Profitable Stocks to Invest in Now. On January 26, 2026, Copart, Inc. (NASDAQ:CPRT) strengthened its financial flexibility ...
Shares of Copart Inc. CPRT rallied 1.20% to $40.36 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.97% to 6,932.30 and the ...
Other Popular Stocks
Formula Systems (1985) Ltd. (FORTY) is an international information technology company providing software solutions and professional services.
MarketAxess Holdings Inc. (MKTX) is a financial technology company providing electronic trading platforms and market data services for fixed income securities.
Cullinan Therapeutics Inc. (CGEM) is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology drug candidates for cancer treatment.